HOUSTON (AP) _ Aravive, Inc. (ARAV) on Wednesday reported a loss of $4.7 million in its first quarter.
On a per-share basis, the Houston-based company said it had a loss of 42 cents.
The biopharmaceutical company posted revenue of $1.7 million in the period.
Aravive shares have climbed 82% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.42, a decline of 29% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARAV at https://www.zacks.com/ap/ARAV